ロード中...
Frequency and distribution of various rheumatic disorders associated with checkpoint inhibitor therapy
Immune checkpoint inhibitors have advanced the treatment paradigm of various cancers, achieving remarkable survival benefits. However, a myriad of immune-related adverse events (irAE) has been recognized in almost every organ system, presumably because of persistent immune system activation. Rheumat...
保存先:
| 出版年: | Rheumatology (Oxford) |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6900912/ https://ncbi.nlm.nih.gov/pubmed/31816084 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rheumatology/kez297 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|